A fatal case of primary amebic meningoencephalitis (PAM) in a 5-month-old infant is described. The disease may have been contracted during bathing. The source of water was from an artificial well. The clinical presentation, the isolation of the ameba from the cerebrospinal fluid, the poor response to amphotericin B, and the ultimate fatal outcome are all consistent with the diagnosis of PAM. On the basis of its ability to grow at temperatures above 30°C, the morphology of the trophozoite, and the presence of flagellate forms, the ameba was identified as Naegleria fowleri. Pathogenic N. fowleri amebae were recovered from samples of water from the well. To our knowledge this case represents the second case of PAM in an infant in the absence of the history of swimming.Naegleria fowleri, a free-living ameba, is ubiquitous and worldwide in distribution. It can infect humans and cause significant disease. It penetrates through the cribriform plate and can cause fulminant and rapidly fatal meningoencephalitis. Most of the infections have been associated with bathing in streams, ponds or lakes, and indoor swimming baths where the water is warm (7). We report on a case of primary amebic meningoencephalitis (PAM) in an infant who had not been swimming. To our knowledge this is the first case of PAM to be reported in Mangalore, India.Case history. A 5-month-old infant presented with a history of fever, vomiting for 1 week, and convulsions for 3 days. On physical examination, the child was febrile (38.5°C), continuous convulsions were present, and the pupils were reactive. There was a progressive deterioration of consciousness, leading to coma. There was no significant finding in the cardiovascular system or respiratory system or by abdominal examination. A computed tomography scan showed mild effacement of the basal cisterns and a thin hypodense collection in bilateral frontal convexity, suggesting a possibility of subdural hygroma or subdural effusion.Laboratory data included a total leukocyte count of 7,300/ mm 3 , with 71% neutrophils, 26% lymphocytes, and 3% eosinophils. The hemoglobin concentration was 10.2 g/dl. No parasites were seen in the peripheral smear. The blood electrolyte picture showed sodium at 133 mmol/liter, potassium at 4.4 mmol/liter, chloride at 95 mmol/liter, bicarbonate at 18.6 mmol/liter, phosphorus at 4.7 mg/dl, blood urea nitrogen at 14 mg/dl, a serum calcium level of 9.2 mg%, and a random blood sugar level of 120 mg/dl.The cerebrospinal fluid (CSF) was cloudy and hemorrhagic; and analysis showed the presence of sugar at a concentration of 10 mg/dl, proteins at a concentration of 361 mg/dl, and a cell count of 130 cells/mm 3 , with 80% neutrophils and 20% lymphocytes. Gram staining showed numerous polymorphonuclear leukocytes but no bacteria. Examination of a wet mount showed actively motile trophozoites suggestive of PAM. A Giemsa-stained smear showed trophozoites.CSF sediment culture on 1.5% nonnutrient agar preseeded with a lawn culture of Escherichia coli yielded oval, motile, flagellated for...
Background:Cryptococcus neoformans is the most common fungal pathogen to infect the central nervous system, and an effective diagnostic method is therefore necessary for the early diagnosis of cryptococcal meningitis.Aim:The efficacy of India ink preparation, cerebrospinal fluid (CSF) culture and CSF cryptococcal antigen detection by the latex agglutination test for diagnosis of cryptococcal meningitis are compared to determine the most efficient test.Materials and Methods:Two hundred CSF samples from human immunodeficiency virus - positive patients suspected to be suffering from meningitis were screened for Cryptococcus neoformans.Results:Latex agglutination for cryptococcal antigen detection was found to be more sensitive compared to India ink staining and CSF culture.Conclusions:Antigen detection by latex agglutination proved to be both sensitive and specific method for the diagnosis of cryptococcal meningitis. Rapid, early diagnosis of infection by detection of cryptococcal antigen by latex agglutination may alter the prognosis for these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.